A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer

BJU International

Volumn 101, Issue 5, 2008, Pages 556-560

  Briganti, Alberto ^a,b   Gallina, Andrea ^a,b   Suardi, Nazareno ^a,b   Chun, Felix K H ^b,c   Walz, Jochen ^b,c   Heuer, Roman ^c   Salonia, Andrea ^a   Haese, Alexander ^c   Perrotte, Paul ^b   Valiquette, Luc ^b   Graefen, Markus ^c   Rigatti, Patrizio ^a   Montorsi, Francesco ^a   Huland, Hartwig ^c   Karakiewicz, Pierre I ^b,d  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF HAMBURG   (Germany)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Lymph node invasion; Nomogram; Pelvic lymphadenectomy; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; GLEASON SCORE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; TUMOR BIOPSY;

ADULT; AGED; COHORT STUDIES; DECISION TREES; EUROPE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REFERENCE STANDARDS; REGRESSION ANALYSIS;

EID: 38849206278     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07321.x     Document Type: Article

References (21)

1. Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001 91 : 66 73.
2. Partin AW, Kattan MW, Subong EN et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997 277 : 1445 51.
3. Kattan MW, Stapleton AM, Wheeler TM, Scardino PT. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer 1997 79 : 528 37.
4. Cagiannos I, Karakiewicz P, Eastham JA et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 2003 170 : 1798 803.
5. Blute ML, Bergstralh EJ, Partin AW et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol 2000 164 : 1591 5.
6. Graefen M, Augustin H, Karakiewicz PI et al. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. Eur Urol 2003 43 : 6 10.
7. Penson DF, Grossfeld GD, Li YP, Henning JM, Lubeck DP, Carroll PR. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor. J Urol 2002 167 : 1653 7.
8. Augustin H, Eggert T, Wenske S et al. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer. J Urol 2004 171 : 177 81.
9. Steuber T, Karakiewicz PI, Augustin H et al. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions. J Urol 2005 173 : 737 41.
10. Briganti A, Chun FK, Salonia A et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 2006 50 : 1006 13.
11. Chun FK, Karakiewicz PI, Briganti A et al. Prostate cancer nomograms: an update. Eur Urol 2006 50 : 914 26.
12. Conrad S, Graefen M, Pichlmeier U, Henke RP, Hammerer PG, Huland H. Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma. J Urol 1998 159 : 2023 9.
13. Briganti A, Chun FK, Salonia A et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 2006 49 : 1019 26.
14. Palapattu GS, Allaf ME, Trock BJ, Epstein JI, Walsh PC. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy. results of long-term followup. J Urol 2004 172 : 1860 4.
15. DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 2005 173 : 1121 5.
16. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 1999 341 : 1781 8.
17. Briganti A, Chun FK, Salonia A et al. A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer. Eur Urol 2007 51 : 112 9.
18. Steuber T, Graefen M, Haese A et al. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. J Urol 2006 175 : 939 44.
19. Chun FK, Briganti A, Graefen M et al. Development and external validation of an extended repeat biopsy nomogram. J Urol 2007 177 : 510 5.
20. Chun FK, Graefen M, Briganti A et al. Initial biopsy outcome prediction - head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 2007 51 : 1236 40.
21. Chun FK, Karakiewicz PI, Briganti A et al. Critical appraisal of prostate cancer logistic regression-based nomograms, artificial neural networks, classification and regression tree models, look-up tables and risk group stratification models. BJU International 2007 99 : 794 800.